November 25, 2016
4 min watch
Save

VIDEO: Burmester reviews sarilumab trial

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

WASHINGTON — At the American College of Rheumatology Annual Meeting, Gerd Burmester, MD, professor of medicine and clinical researcher at the Charit University Hospital in Berlin, reviewed the MONARCH trial, a head-to-head study that demonstrated sarilumab was superior to adalimumab.